Announcements Trials

Browse Landscape

Phase

Status

Completed 5 Terminated 2 Unknown 1

Sponsor Class

OTHER 6 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

Injections 54 Cisplatin 49 Paclitaxel 48 Carboplatin 43 Gemcitabine 38 pembrolizumab 36 Docetaxel 36 Capecitabine 36 Drug Therapy 34 anlotinib 25 Bevacizumab 25 Fluorouracil 24 Cyclophosphamide 24 icotinib 23 Oxaliplatin 20 fludarabine 19 Pemetrexed 17 Leucovorin 16 Irinotecan 16 Temozolomide 14 Nivolumab 14 Doxorubicin 14 Cetuximab 14 camrelizumab 13 apatinib 13 Trastuzumab 12 Rituximab 11 Fulvestrant 11 Etoposide 11 tesetaxel 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × INDUSTRY × Homoharringtonine × Clear all

NCT04716114 2021-11-02

ALIVE

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 3 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡